Skip to main content

Security report for 360biolabs.com

360biolabs · Healthcare · Australia

Medium risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

65/100

Risk levelMedium

0–100, higher is better. How it is calculated

360biolabs is a specialized bioanalytical laboratory based in Australia, offering a comprehensive suite of services including pharmacokinetics, pharmacodynamics, immunogenicity, biomarker analysis, and infectious disease testing. The company positions itself as a leader in early-phase clinical study support, leveraging the Australian regulatory and economic advantages. It operates as a subsidiary or affiliate of BioAgilytix, a global bioanalytical services provider, with multiple international locations enhancing its global reach. Technically, the website is built on WordPress and employs modern web technologies such as jQuery, Google Tag Manager, and HubSpot Analytics. The site is well-optimized for mobile devices, has good SEO practices, and includes a cookie consent mechanism compliant with privacy regulations. The performance is moderate with a professional design and clear navigation. From a security perspective, the site uses HTTPS with good SSL configuration and includes cookie consent for privacy compliance. However, it lacks explicit security headers and published security or incident response policies. The absence of WHOIS registration data for the domain is a notable concern, although the website content and external references suggest legitimacy. Overall, the website presents a professional and trustworthy front for a healthcare service provider but would benefit from enhanced transparency in domain registration and security policies to improve trust and compliance posture.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching 360biolabs.com

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
50
Email security
85
DNS health
85
Network security
40
GDPR outside view
68
Average
65

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

360biolabs operates in the healthcare sector, focusing on bioanalytical laboratory services for clinical research. Its competitive advantage lies in its Australian base, offering regulatory speed, cost incentives, and quality assurance recognized internationally. The business model is service-oriented, targeting pharmaceutical and biotech companies conducting early-phase clinical trials. The partnership with BioAgilytix expands its market reach and resource base. The company emphasizes scientific excellence and innovation, supported by a team of over 50 PhD scientists and a global team exceeding 1000 members. The website content and structure indicate a mature organization with a medium-sized footprint and a clear focus on quality and compliance.

Security posture

The website demonstrates a moderate to good security posture with enforced HTTPS and cookie consent mechanisms. However, it lacks several recommended security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options, which could mitigate common web vulnerabilities. No security or incident response policies are published, and no dedicated security contact channels are provided. The absence of WHOIS data raises questions about domain registration transparency. No vulnerabilities or exposed sensitive data were detected in the HTML content. Overall, the security maturity is adequate for a marketing website but could be improved to align with best practices for healthcare-related services.

Recommendations

  1. Publish and enforce comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
  2. Provide a publicly accessible security policy and incident response contact information to enhance transparency and trust.
  3. Verify and update WHOIS domain registration information to ensure consistency and legitimacy.
  4. Regularly audit third-party scripts and tracking tools to minimize privacy risks and improve compliance.
  5. Enhance data protection disclosures and consider appointing a Data Protection Officer with contact details.

Contact details published on the site

Addresses
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
360biolabs
Description
Australia's leading bioanalytical laboratory, providing comprehensive services for early-phase clinical studies including pharmacokinetics, pharmacodynamics, immunogenicity, biomarkers, vaccines, infectious diseases, and central lab services.
Key services
Pharmacokinetics, Pharmacodynamics, Immunogenicity, Biomarkers, Vaccines and Infectious Diseases, Central Lab Services
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, Google Tag Manager, HubSpot Analytics, TagEmbed Widget
Performance
moderate
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism
  • No exposed sensitive data in HTML

Analytics and tracking

Services
HubSpot Analytics, Google Analytics (via GTM), LinkedIn Insight
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Facebook Ads (hsadspixel.net)
Tracking pixels
HubSpot Analytics, LinkedIn Insight Tag
Marketing tools
HubSpot, TagEmbed
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and no blocking mechanisms.
  2. Strong branding and consistent design aligned with healthcare bioanalytical services.
  3. Comprehensive service descriptions and global locations provided.
  4. Cookie consent and privacy policy are implemented properly.
  5. No direct company contact emails or phone numbers found in HTML; contact via form and addresses only.
  6. WHOIS data missing, which is a concern for domain legitimacy verification.
  7. Use of multiple third-party marketing and analytics tools.
  8. No explicit security or incident response policies published.
Technical notes

Notes

The website is built on WordPress CMS with a modern front-end stack including jQuery and asynchronous loading of analytics and marketing scripts. It uses Google Tag Manager for tag management and HubSpot for marketing automation and analytics. The site is mobile-optimized with responsive design and good accessibility features. Performance is moderate, with some reliance on external scripts which may impact load times. The site uses a cookie consent banner compliant with GDPR and other privacy regulations. There is no evidence of technical debt or deprecated technologies, but security header implementation is incomplete. Hosting provider details are not explicitly found in the HTML content.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with 360biolabs.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review 360biolabs.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.